DeutschNewstral
Article
Forbes on 2024-02-06 16:30
Tesla Now Worth $110 Billion Less Than Weight Loss Drug Maker Eli Lilly
Related news
- DEli Lilly leaps as weight-loss-drug sales drive earnings and 2024 outlookdcourier.com
- Weight-Loss Drug Frenzy Drives Eli Lilly And Novo Nordisk Stock To Record HighsForbes
Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heightstimesfreepress.com
Eli Lilly & Co: Eli Lilly to invest extra $5.3bn in manufacturing site for weight loss drugsFinancial Times- FEli Lilly & Co: Eli Lilly lifts outlook on bumper sales of diabetes and weight loss drugsft.com
- FEli Lilly & Co: Eli Lilly launches cut-price version of blockbuster weight-loss drugft.com
- Eli Lilly & Co: Eli Lilly to seek obesity drug approval that could disrupt weight loss marketFinancial Times
- Eli Lilly & Co: Eli Lilly weight-loss drug found to address sleep apnoea in trialFinancial Times
- DEli Lilly slumps after disappointing Zepbound weight-loss-drug trialdcourier.com
Diabetes, weight drugs earn Eli Lilly $4B in 2Qnwaonline.com
Eli Lilly weight loss drug Zepbound approved by the FDANew York Post- MEli Lilly releases new, cheaper type of weight reduction drugmvtelegraph.com
- MEli Lilly weight reduction drug tirzepatide knowledge launchedmvtelegraph.com
- FEli Lilly & Co: Eli Lilly races to boost capacity for rival to Novo Nordisk weight-loss drugft.com
- DAnalysts revamp Eli Lilly stock price target on weight-loss drugsdcourier.com
Sleep apnea reduced in people who took weight-loss drug, Eli Lilly reportsThe New York Times- MEli Lilly weight reduction drug cuts threat of creating diabetes in trialmvtelegraph.com
- DAnalyst revamps Eli Lilly stock price target on weight loss drugdcourier.com